| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total current assets | 13,512,928 | 10,815,125 | ||
| Non-current prepaid clinical trial costs | 819,721 | 819,721 | ||
| Total assets | 14,332,649 | 11,634,846 | ||
| Total stockholders' equity | 4,549,735 | -459,147 | ||
| Total liabilities and stockholders equity | 14,332,649 | 11,634,846 | ||
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)